-
Vineti Opens New Regional HQ in Maryland
contractpharma
May 29, 2019
New office expansion further enables accelerated cell and gene therapy clinical development and commercial operations in the Eastern United States.
-
FDA Approves First Gene Therapy Zolgensma (Onasemnogene Abeparvovec-xioi) for Spinal Muscular Atrophy
drugs
May 29, 2019
FDA Approves First Gene Therapy Zolgensma (Onasemnogene Abeparvovec-xioi) for Spinal Muscular Atrophy.
-
Do You Have the 'Fainting Gene'?
drugs
May 29, 2019
Some folks are more prone to fainting than others, and the reason might lie in their DNA.
-
New Gene Variants for Type 2 Diabetes Found
drugs
May 24, 2019
New Gene Variants for Type 2 Diabetes Found.
-
Catalent Completes Paragon Acquisition
contractpharma
May 21, 2019
$1.2 billion deal for gene therapy leader is final.
-
Solid tanks as safety scare again rocks DMD gene therapy
fiercebiotech
May 15, 2019
A safety scare has rocked Solid Biosciences’ drive to get its Duchenne muscular dystrophy (DMD) gene therapy program back on track.
-
Prostate cancer mutation found to triple risk of death
pharmatimes
May 09, 2019
Prostate cancer mutation found to triple risk of death.
-
Microcapsules to enhance the efficiency of genome-editing
europeanpharmaceuticalreview
May 06, 2019
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing…
-
Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland
firstwordpharma
April 26, 2019
GERMANTOWN, Md., April 25, 2019 /PRNewswire/ -- Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) and ...
-
Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy
b3cnewswire
April 23, 2019
Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy.